Seizure Associated with Clozapine: Incidence, Etiology, and Management.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 101, doi. 10.1007/s40263-014-0222-y
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2015 AND VI 29 AND IP 2
Results: 8
1
2
Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 113, doi. 10.1007/s40263-015-0230-6
- By:
- Publication type:
- Article
3
The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 131, doi. 10.1007/s40263-014-0224-9
- By:
- Publication type:
- Article
4
Taming Glutamate Excitotoxicity: Strategic Pathway Modulation for Neuroprotection.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 153, doi. 10.1007/s40263-015-0225-3
- By:
- Publication type:
- Article
5
Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 171, doi. 10.1007/s40263-015-0227-1
- By:
- Publication type:
- Article
6
Weight Regain after Discontinuation of Topiramate Treatment in Patients with Migraine: a Prospective Observational Study.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 163, doi. 10.1007/s40263-015-0229-z
- By:
- Publication type:
- Article
7
mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 91, doi. 10.1007/s40263-014-0223-x
- By:
- Publication type:
- Article
8
Role of Apomorphine in the Treatment of Parkinson's Disease.
- Published in:
- CNS Drugs, 2015, v. 29, n. 2, p. 83, doi. 10.1007/s40263-014-0221-z
- By:
- Publication type:
- Article